Thus, our finding that MEQ inhibited the expression of VEGFA in TNBC through the MTA2/SerRS/VEGFA pathway revealed the underlying mechanism for isoflavones and their derivatives, allowing the optimization of this natural molecule for cancer treatment. Here, VEGFA is linked to cancer.